Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Atherosclerosis

• Publication date

  2006-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.ATHEROSCLEROSIS.2005.10.017PMID 16307748
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA)

  2005cited by this paper
• Absolute and relative changes in carotid intima–media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA)

  2004cited by this paper
• Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis

  2003cited by this paper
• Oxidised LDL modulates immune-activation by an IL-12 dependent mechanism.

  2003cited by this paper
• Serum Heat Shock Protein 70 Levels Predict the Development of Atherosclerosis in Subjects With Established Hypertension

  2003cited by this paper
• Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL

  2003cited by this paper
• Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial

  2002cited by this paper
• Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.

  2002cited by this paper
• Protective role of phospholipid oxidation products in endotoxin-induced tissue damage

  2002cited by this paper
• Innate and acquired immunity in atherogenesis

  2002cited by this paper
• Autoimmunity, oxidized LDL and cardiovascular disease.

  2002cited by this paper
• B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Antibodies to Oxidized LDL in Relation to Carotid Atherosclerosis, Cell Adhesion Molecules, and Phospholipase A2

  2001cited by this paper
• Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus

  2001cited by this paper
• The Binding of Oxidized Low Density Lipoprotein to Mouse CD36 Is Mediated in Part by Oxidized Phospholipids That Are Associated with Both the Lipid and Protein Moieties of the Lipoprotein*

  2000cited by this paper
• Immunological responses to oxidized LDL.

  2000cited by this paper
• Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.

  2000cited by this paper
• Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines.

  1999cited by this paper
• Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.

  1999cited by this paper
• Autoantibodies to OxLDL are decreased in individuals with borderline hypertension.

  1999cited by this paper
• Phosphorylcholine: friend or foe of the immune system?

  1999cited by this paper
• Antiphosphorylcholine Antibody Levels Are Elevated in Humans with Periodontal Diseases

  1999cited by this paper
• Risk factors associated with alterations in carotid intima—media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis

  1998cited by this paper
• Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism.

  1997cited by this paper
• Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL.

  1995cited by this paper
• T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.

  1995cited by this paper
• Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.

  1995cited by this paper
• Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.

  1995cited by this paper
• Autoantibody against oxidised LDL and progression of carotid atherosclerosis.

  1992cited by this paper
• Induction of T-cell activation by oxidized low density lipoprotein.

  1992cited by this paper
• Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65.

  1992cited by this paper
• Biologically modified LDL increases the adhesive properties of endothelial cells.

  1991cited by this paper
• Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.

  1990cited by this paper
• High anti-phosphorylcholine antibody levels and mortality associated with pneumonia.

  1990cited by this paper
• Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937.

  1990cited by this paper
• Subpopulations of antibodies to phosphocholine in human serum.

  1984cited by this paper
• Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae

  1982cited by this paper

• Plasma levels of anti phosphocholine IgM antibodies are negatively correlated with bone mineral density in humans

  2025cites this paper
• Antibodies Against Phosphorylcholine in Prediction of Cardiovascular Disease Among Women

  2024cites this paper
• Vaccination as a Promising Approach in Cardiovascular Risk Mitigation: Are We Ready to Embrace a Vaccine Strategy?

  2024cites this paper
• Molecular Links and Clinical Effects of Inflammation and Metabolic Background on Ischemic Stroke: An Update Review

  2024cites this paper
• Canonical and non-canonical roles of complement in atherosclerosis

  2024cites this paper
• Antibodies against malondialdehyde among 60-year-olds: prediction of cardiovascular disease

  2023cites this paper
• Methods on LDL particle isolation, characterization, and component fractionation for the development of novel specific oxidized LDL status markers for atherosclerotic disease risk assessment

  2023cites this paper
• Impact of RYGB surgery on plasma immunoglobulins: association between blood pressure and glucose levels six months after surgery

  2023cites this paper
• Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases

  2023cites this paper
• Antibodies against phosphorylcholine and protection against atherosclerosis, cardiovascular disease and chronic inflammation

  2022cites this paper
• Trained Immunity as a Trigger for Atherosclerotic Cardiovascular Disease—A Literature Review

  2022cites this paper
• Systemic lupus erythematosus and cardiovascular disease

  2022cites this paper
• Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial.

  2022cites this paper
• Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions

  2022cites this paper
• A Jack of All Trades: The Role of Pneumococcal Surface Protein A in the Pathogenesis of Streptococcus pneumoniae

  2022cites this paper
• A nasal double DNA adjuvant system induces atheroprotective IgM antibodies via dendritic cell-B-1a B cell interactions.

  2022cites this paper
• Associação Positiva entre Autoanticorpos contra LDL Oxidada e HDL-C: Um Novo Mecanismo para Cardioproteção de HDL?

  2022cites this paper
• The potential targets in immunotherapy of atherosclerosis

  2021cites this paper
• Autoantibodies Against ApoB-100 as a New Marker of Coronary Vulnerable Plaque

  2021cites this paper
• The Influence of a Conjugated Pneumococcal Vaccination on Plasma Antibody Levels against Oxidized Low-Density Lipoprotein in Metabolic Disease Patients: A Single-Arm Pilot Clinical Trial

  2021cites this paper
• Using Anti-Malondialdehyde Modified Peptide Autoantibodies to Import Machine Learning for Predicting Coronary Artery Stenosis in Taiwanese Patients with Coronary Artery Disease

  2021cites this paper
• Potential natural immunization against atherosclerosis in hibernating bears

  2021cites this paper
• Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

  2021cites this paper
• IgM Immunoglobulin Influences Recovery after Cervical Spinal Cord Injury by Modulating the IgG Autoantibody Response

  2021cites this paper
• Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects

  2021cites this paper
• Promoting athero-protective immunity by vaccination with low density lipoprotein-derived antigens.

  2021cites this paper
• Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality

  2020cites this paper
• Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes

  2020cites this paper
• IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases

  2020cites this paper
• SERUM LEVELS OF ANTIBODIES AGAINST OXIDATION-SPECIFIC EPITOPES ARE DECREASED IN PATIENTS WITH RETINAL VEIN OCCLUSION

  2020cites this paper
• Current Understanding of Natural Antibodies and Exploring the Possibilities of Modulation Using Veterinary Models. A Review

  2020cites this paper
• The Effect of a 13-Valent Conjugate Pneumococcal Vaccine on Circulating Antibodies Against Oxidized LDL and Phosphorylcholine in Man, A Randomized Placebo-Controlled Clinical Trial

  2020cites this paper
• Antibodies against Phosphorylcholine and Malondialdehyde during the First Two Years of Life

  2020cites this paper
• Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases

  2020cites this paper
• Immunoglobulin G1 Antibodies Against Phosphorylcholine Are Associated With Protection in Systemic Lupus Erythematosus and Atherosclerosis: Potential Underlying Mechanisms

  2020cites this paper
• Phenotypic features of vascular calcification in chronic kidney disease

  2019cites this paper
• Associations of low HDL cholesterol level and premature coronary heart disease with functionality and phospholipid composition of HDL and with plasma oxLDL antibody levels

  2019cites this paper
• Role of Phosphorylcholine-Specific Immunoglobulin M in Acute Upper Respiratory Tract Infections

  2019cites this paper
• Gluten-free diet in non-celiac patients: beliefs, truths, advantages and disadvantages.

  2019cites this paper
• Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice.

  2019cites this paper
• Analysis of fragmented oxidized phosphatidylcholines in human plasma using mass spectrometry: Comparison with immune assays.

  2019cites this paper
• IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.

  2018cites this paper
• Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders.

  2018cites this paper
• Aprahamian, Tamar R. and Zhong, Xuemei and Amir, Shahzada and Binder, Christoph J. and Chiang, Lo-Ku and Al-Riyami, Lamyaa and Gharakhanian, Raffi and Harnett, Margaret M. and Harnett, William and Rifkin,

  2018cites this paper
• Linking autoimmunity to the origin of the adaptive immune system

  2018cites this paper
• Nontypeable Haemophilus influenzae Invasive Blood Isolates Are Mainly Phosphorylcholine Negative and Show Decreased Complement-Mediated Killing That Is Associated with Lower Binding of IgM and CRP in Comparison to Colonizing Isolates from the Oropharynx

  2018cites this paper
• Reduction of myocardial ischaemia–reperfusion injury by inactivating oxidized phospholipids

  2018cites this paper
• The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology

  2018cites this paper
• Readapting the adaptive immune response – therapeutic strategies for atherosclerosis

  2017cites this paper
• Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody

  2017cites this paper
• Antibodies against Phosphorylcholine among New Guineans Compared to Swedes: An Aspect of the Hygiene/Missing Old Friends Hypothesis

  2017cites this paper
• 170829 Grönwall et al IgM in SLE arxiv

  2017cites this paper
• X-Box Binding Protein-1 Dependent Plasma Cell Responses Limit the Development of Atherosclerosis

  2017cites this paper
• Readapting the adaptive immune response – therapeutic strategies for atherosclerosis

  2017cites this paper
• X-box Binding Protein-1 dependent Plasma Cell Responses Limit the Development of Atherosclerosis

  2017cites this paper
• Cardiolipin Regulates Mitophagy through the Protein Kinase C Pathway*

  2017cites this paper
• Depressed serum IgM levels in SLE are restricted to defined subgroups.

  2017cites this paper
• IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.

  2016cites this paper
• Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect

  2016cites this paper
• Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60‐Year‐Olds

  2016cites this paper
• Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair

  2016cites this paper
• Natural Antibodies as Rheostats for Susceptibility to Chronic Diseases in the Aged

  2016cites this paper
• Phosphorylcholine antibodies are diminished in ANCA‐associated vasculitis

  2015cites this paper
• The human counterpart of mouse B‐1 cells

  2015cites this paper
• Malondialdehyde-Modified LDL IgG Antibody Levels and Indices of Cardiac Function in Valvular Heart and Coronary Artery Disease Patients

  2015cites this paper
• This information is current as Subjects Cardiovascular Events in Nondiabetic Apolipoprotein B 100 Peptide Predict Modified − Advanced Glycation Endproduct Low Levels of IgM Antibodies against an

  2015cites this paper
• Circulating Autoantibodies against the Apolipoprotein B-100 Peptides p45 and p210 in Relation to the Occurrence of Carotid Plaques in 64-Year-Old Women

  2015cites this paper
• Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies.

  2015cites this paper
• Prediction and management of cardiovascular outcomes in systemic lupus erythematosus

  2015cites this paper
• Low Levels of IgM Antibodies against an Advanced Glycation Endproduct–Modified Apolipoprotein B100 Peptide Predict Cardiovascular Events in Nondiabetic Subjects

  2015cites this paper
• Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease.

  2015cites this paper
• The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse model.

  2015cites this paper
• Splenic extrafollicular reactions and BM plasma cells sustain IgM response associated with hypercholesterolemia

  2015cites this paper
• Naturally Occurring Human Phosphorylcholine Antibodies Are Predominantly Products of Affinity-Matured B Cells in the Adult

  2014cites this paper
• B Cells in the Adult Predominantly Products of Affinity-Matured Phosphorylcholine Antibodies Are Naturally Occurring Human

  2014cites this paper
• Human monoclonal Fab and human plasma antibodies to carbamyl‐epitopes cross‐react with malondialdehyde‐adducts

  2014cites this paper
• The Role of Modified Forms of LDL and Corresponding Autoantibodies in the Development of Complications in Diabetes

  2014cites this paper
• IgM-Antibodies against Phosphorylcholine in Mothers and Normal or Low Birth Weight Term Newborn Infants

  2014cites this paper
• Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease

  2014cites this paper
• Natural IgM: Beneficial Autoantibodies for the Control of Inflammatory and Autoimmune Disease

  2014cites this paper
• Humoral immune response to carbamyl-epitopes in atherosclerosis

  2014cites this paper
• Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development

  2014cites this paper
• Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men.

  2014cites this paper
• Women with overweight, mixed hyperlipidemia, intolerance to glucose and diastolic hypertension

  2014cites this paper
• Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial

  2014cites this paper
• Immune Mechanisms in Atherosclerosis, Especially in Diabetes Type 2

  2013cites this paper
• IMMUNOASSAY OF MODIFIED FORMS OF HUMAN LOW DENSITY LIPOPROTEIN IN ISOLATED CIRCULATING IMMUNE COMPLEXES

  2013cites this paper
• IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes.

  2013cites this paper
• Auto-antibodies as Emergent Prognostic Markers and Possible Mediators of Ischemic Cardiovascular Diseases

  2013cites this paper
• Anti-phosphorylcholine antibodies in cardiovascular disease

  2013cites this paper
• Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosis.

  2013cites this paper
• Chapter 2 Future potential biomarkers for post-interventional restenosis and accelerated atherosclerosis

  2013cites this paper
• Immunity, atherosclerosis and cardiovascular disease

  2013cites this paper
• Low levels of a natural IgM antibody are associated with vein graft stenosis and failure.

  2013cites this paper
• Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study

  2013cites this paper
• Characterization of human anti-heat shock protein 60 monoclonal autoantibody Fab fragments in atherosclerosis: genetic and functional analysis.

  2013cites this paper
• Passive Immunization with Hypochlorite-oxLDL Specific Antibodies Reduces Plaque Volume in LDL Receptor-Deficient Mice

  2013cites this paper
• Molecular and psychosocial risk factors for cardiovascular disease

  2013cites this paper
• Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases

  2013cites this paper
• Adaptive Immunity in Cardiovascular Disease

  2013cites this paper